|
Market Closed -
OTC Markets
05:55:28 05/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.0268 USD | +3.08% |
|
-4.29% | +3.08% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 18/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 7.1M | - | - | - | - | - |
| 82.65B | |||||
| 60.24B | |||||
| 58.11B | - | ||||
| 49.68B | |||||
| 46.66B |
Select your edition
All financial news and data tailored to specific country editions
